CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-10 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −7,875 | $452.04 | $3.6M | 0 |
| 2025-11-10 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −14,625 | 26,625 | ||
| 2025-11-10 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −7,875 | 2,625 | ||
| 2025-11-10 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion 10b5-1 | +21,000 | $146.03 | $3.1M | 29,118 |
| 2025-11-10 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,052 | $446.51 | $470K | 28,066 |
| 2025-11-10 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,539 | $447.47 | $689K | 26,527 |
| 2025-11-10 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −3,356 | $448.33 | $1.5M | 23,171 |
| 2025-11-10 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −653 | $449.00 | $293K | 22,518 |
| 2025-11-10 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −600 | $450.80 | $270K | 21,918 |
| 2025-11-10 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,065 | $451.87 | $481K | 20,853 |
| 2025-11-10 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,170 | $452.76 | $982K | 18,683 |
| 2025-11-10 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −4,633 | $453.81 | $2.1M | 14,050 |
| 2025-11-10 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −3,342 | $454.82 | $1.5M | 10,708 |
| 2025-11-10 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,590 | $455.83 | $1.2M | 8,118 |
| 2025-11-10 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion · Stock Option 10b5-1 | −21,000 | 10,312 | ||
| 2025-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,500 | $448.27 | $1.6M | 630 |
| 2025-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $449.22 | $225K | 130 |
| 2025-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 110,000 | ||
| 2025-11-07 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
Page 184 of 214 · 4,273 trades